Skip to content

Clinical trials

Terminated Muscular Dystrophy, Duchenne trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Status: Terminated Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20121
20133
20141
20161
20182
20192
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical3
Kyntra Bio2
PTC Therapeutics2
Santhera Pharmaceuticals2
Sarepta Therapeutics, Inc.2
Assistance Publique - Hôpitaux de Paris1
Eli Lilly and Company1
GlaxoSmithKline1
Wave Life Sciences USA, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne15
Muscular Dystrophies4
Muscular Diseases3
Neuromuscular Diseases3
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscular Disorders, Atrophic2
Musculoskeletal Diseases2
Nervous System Diseases2
Amyotrophic Lateral Sclerosis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.